mutares sells Suir Pharma Ireland
The Munich-based restructuring specialist mutares AG (ISIN: DE000A0SMSH2) has sold the pharmaceutical contract manufacturer Suir Pharma Ireland to the strategic investor Saneca Pharmaceuticals. With its second successful exit in 2015, mutares further streamlines its portfolio. Suir Pharma Ireland (SPI) was acquired in 2012 from German STADA Group. It operates as a Contract Manufacturing Organisation (CMO) […]